Equinom’s mission: breeding future foods and bringing sustainable solutions to the food industry.
Founded in 2012 by Dr. Gil Shalev, and backed by investors including Israeli seed and field crop specialist Hazera 1939, Equinom made its first inroads breeding pepper varieties in the Arava in Israel, where utilizing our proprietary technology we developed varieties of pepper with 20% higher yield, a project that expanded to Mexico and is currently in commercial phases.
We then revolutionized the sesame market by removing its key barrier --the requirement that it be harvested manually, solving a 3,000 year-old problem.
Our current focus is plant protein, where we are set to accelerate the development of a sustainable, reliable and healthier alternative to soy, which despite its disadvantages, has a 77% market share.
Equinom is committed to working with the food industry (and its supply chain) to create better food ingredients, containing only what nature has given us. Since inception, we have developed partnerships with global companies including Sabra, a PepsiCo subsidiary. Our goal is to continue developing products that transform markets by changing their economics.
Dr. Gil Shalev, CEO
Gil is the driving force behind Equinom, and the founder of the company. Prior to establishing Equinom, he held senior roles at Hazera Genetics and Vilmorin & Cie.
Avi Posen, Vice President Business Development
Avi brings over 18 years of experience in business development, sales, and executive management. Prior to joining Equinom he served as the Vice President of Sales at Mazor Robotics.
Dr. Oron Gar, Product Manager - Field Crops
Oron manages sesame and quinoa breeding at Equinom. Throughout his career, Oron has been involved in developing advanced statistical and bioinformatics tools for analyzing large databases.
Dr. Sigal Meirovitch, Product Manager - Protein
Sigal manages protein projects at Equinom. She brings over 10 years of experience in biotechnology R&D and R&D management. Her scientific achievements include five international patents in the field of protein engineering and biopolymer production.
Prof. Oded Shoseyov
Prof. Oded Shoseyov is a faculty member at the Hebrew University. His main field of research is plant molecular biology and biotechnology. He has extensive experience in genetic engineering of plants, protein engineering and nano-biotechnology. Prof. Shoseyov has authored or co-authored more than 160 scientific publications and is the inventor or co-inventor of 42 patents. He is the scientific founder of CBD Technologies and FuturaGene, and co-founder of Fulcrum-SP and Melodea, Bondex and Collplant.
Prof. Abraham Korol
Prof. Abraham Korol is the head of the Institute of Evolution at the University of Haifa, Israel. The research in his laboratory involves population genetics, evolution of sex and recombination, evolution of plant domestication, sequence comparisons at the above-gene level and genome mapping. He is the CEO of MultiQTL Ltd., a bioinformatics company aimed at developing a spectrum of software tools for genomics and biotechnology.
Prof. Amram Ashri
Professor Emeritus of genetics and breeding at the Hebrew University, Amram Ashri is one of the pioneering genetic researchers in sesame, and has been involved in oilseed breeding and genetics research projects for close to 50 years. One of his major achievements was to establish a large world collection of cultivated and some wild Sesamum species with support from the IBPGR (now IPGRI). Over the years, he has served as the Dean of the Hebrew University's Faculty of Agriculture, and as a consultant for international organizations (e.g., FAO, World Bank, IBPGR) and several international NGOs.
Dr. Eitan Rubin
Dr. Eitan Rubin is a bioinformatics, with expertise in the areas of genomics, functional genomics and data-mining. He is a tenured researcher at Ben-Gurion University in the Negev, working in the Faculty of Health Sciences on the applications of bioinformatics approaches to precision cancer medicine. Before joining BGU he was the head of bioinformatics at the Bauer Center for Genomics Research in Harvard University, the head of bioinformatics in the Weizmann Institute of Science, and a research scientist at Compugen Ltd (Tel Aviv, Israel). Dr. Rubin received his PhD from the Weizmann Institute of Science (Faculty of Life Sciences) in 2000. He published over 30 papers and books, presented in numerous conferences around the world, and serves as the head of IT for the WIN consortium, which focuses on promoting Precision Cancer Medicine through clinical trials.
Michael (Micha) Danziger
Micha Danziger is co-General Manager and co-owner of Danziger "Dan" Flower Farm Ltd. and Danziger's main production facility in Kenya—Beauty Line Ltd., and co-owner of Beauty Line Guatemala, the production site supplying the North American market. He is also co-General Manager and co-owner of Danziger Innovations Ltd., a biotechnology company developing innovative and advanced methods for plant breeding that are applicable to a wide range of crops. Micha has over 45 years of experience in the agriculture, floriculture and breeding industries.
Ilan Salmona is an agronomist who has served, over the years, in several senior positions in agriculture and industry. Today he is the CEO of Hazera (1939) Ltd. This company has several farms across the country and specializes in the production of field crop seeds, hybrid seeds of vegetables, and propagation materials for vines and avocado. The company also focuses on partnerships with field crop breeding companies that hold novel technologies.
Reuven Behar is a partner at the law firm Fischer Behar Chen Well Orion & Co. (FBC), where he leads the litigation and antitrust practice. He has handled major mergers and acquisitions (M&A) transactions and is well-known for his IP expertise. From 2006 to 2009, he was the Chairman of Netafim, the world's largest irrigation company.
Nir Linchevski is Managing Partner at Israel Secondary Fund (ISF). Before that, Nir was a founder and partner at Shiraz Investments and the chairman of Altshuler Shaham, a firm with over 50 billion NIS in assets. He has also been a partner at Vantage Point Capital Partners, a US-based venture capital firm, and a partner at Formula Ventures.